Technology

Technology

Technology

Single Cell RNA-seq

Existing scRNA-seq technologies based on template-switching methods are widely used. However, these techniques have problems in the accurate evaluation of cell composition and the sensitivity of gene detection by the template-switching method.

The TAS-Seq method (Terminator-assisted solid-phase cDNA amplification and sequencing) uses a template-independent enzyme, terminal transferase (TdT), a ddNTP terminator terminator for TdT The combination of TdT, a template-independent enzyme, a stochastic stopping mechanism of the TdT reaction by a ddNTP terminator terminator, and microwell/magnetic bead-based cell isolation technology has been shown to detect more genes and highly-variable genes with higher sensitivity than existing methods, regardless of the amount of sequencing. The results of this study are as follows.

Problems with existing scRNA-seq analysis method

Problems with existing scRNA-seq analysis methods

Problems with existing scRNA-seq analysis methods

Depends on sampling bias

Inaccuracy of cell composition data

Depends on sampling bias

Inaccuracy of cell composition data

Limitations of cDNA amplification efficiency by template switching reaction

Limitations of cDNA amplification efficiency by template switching reaction

Solving problems with existing technology with TAS-Seq

Solving problems with existing technologies with TAS-Seq

Efficient cDNA amplification using TdT (terminal transferase)

Efficient cDNA amplification using TdT (terminal transferase)

Nanowell/magnetic bead-based scRNA-seq for improved cell separation

Improved cell separation by nanowell/magnetic bead-based scRNA-seq

by ddNTP terminator

Stochastic cessation of TdT reaction

by ddNTP terminator

Stochastic cessation of TdT reaction

Validation in mouse and human lung samples

Validation in mouse and human lung samples

The TAS-Seq method provides more accurate data than existing technologies, suggesting that it can be useful for detailed understanding of diseases and discovery of new drug targets

The TAS-Seq method provides more accurate data than existing technologies, suggesting that it can be useful for detailed understanding of diseases and discovery of new drug targets

Accurate detection of cellular composition in tissue

Higher gene detection sensitivity

More robust
detection of intercellular communication

More robust
detection of growth factors, IL expression, etc.

Comparison of cell detection accuracy between flow cytometers and various techniques in mouse lung cells

Compared to flow cytometer data, TAS-seq correlates well with flow cytometers and provides accurate cell composition data.

10X v2 data from other methods over-detected macrophages and under-detected fibroblast fractions. (See red box)

Smart-seq2 data over-detected endothelial cells and monocytes and lost alveolar macrophages (see green box).

Shichino S. et al. Communications Biology volume 5, Article number: 602 (2022) 

Accurate measurement of cell composition ratio by TAS-Seq method ( high reproducibility of cell presence frequency)

Accurate measurement of cell composition ratio by TAS-Seq method ( high reproducibility of cell presence frequency)

Detection of intercellular communication in mouse lung

TAS-Seq has the potential to detect important cell-to-cell communication more robustly than other technologies

TAS-Seq has the potential to detect important cell-to-cell communication more robustly than other technologies

Development of TAS-seq2

We have optimized the reaction system of TAS-Seq and developed TAS-Seq2 with even higher detection sensitivity.

10X v3: 10X Chromium v3 (GSE192930) include-intron mode (1.5 times more sensitive than non-intron mode 10X v3)

BD1-BD3 : BD Rhapsody WTA kit TAS-Seq1-1~1-3 : TAS-Seq TAS-Seq2-1~2-3 : TAS-Seq2

10X v3: 10X Chromium v3 (GSE192930) include-intron mode (1.5 times more sensitive than non-intron mode 10X v3)

BD1-BD3 : BD Rhapsody WTA kit TAS-Seq1-1~1-3 : TAS-Seq TAS-Seq2-1~2-3 : TAS-Seq2

10X v3: 10X Chromium v3 (GSE192930) include-intron mode (1.5 times more sensitive than non-intron mode 10X v3)

BD1-BD3 : BD Rhapsody WTA kit
TAS-Seq1-1~1-3 : TAS-Seq TAS-Seq2-1~2-3 : TAS-Seq2

TAS-Seq2detects 1.5-2x more genes than intron-containing 10X Chromium v3 (1.2-1.5x more genes detected than regular Chromium v3)

TAS-Seq2 detects 1.5-2x more genes than intron-containing 10X Chromium v3 (1.2-1.5x more genes detected than regular Chromium v3)

Example of nuclear analysis of cells derived from mouse liver specimen using TAS-Seq2

*10X nuclear conditioning kit with anti-nuclear pore complex hashtags approx. 20000-30000 reads / nucleus

TAS-Seq2 enables more sensitive detection of genes in cell nuclei than other methods

Detects hepatocytes that are difficult to analyze by single-cell RNA-seq due to losses during cell preparation. Hepatocyte clusters specific to histological regions are also identified.

Detects hepatocytes that are difficult to analyze by single-cell RNA-seq due to losses during cell preparation. Hepatocyte clusters specific to histological regions are also identified.

10X v3.1: Published mouse liver sample data (SRX14774301, SRX14774300)

Multiplex Analysis

(Universal Surface Biotinylation : USB method)

Multiplex analysis is a technique that enables simultaneous analysis of multiple samples by using Tag antibodies or streptavidin with DNA barcodes on cells from different sample sources, called cell hashing. We use Universal Surface Biotinylation (USB), a universal labeling technology that does not depend on specific cell surface proteins.

Universal Surface Biotinylation: a simple, versatile and cost-effective sample multiplexing method for single-cell RNA-seq analysis 

TCR Repatoir Analysis

High sensitivity, unbiased

By synthesizing cDNA from mRNA and amplifying the TCR gene with a common primer, IGT's amplification method is more sensitive and unbiased than systems that start with cDNA and amplify the variable region with multiple primers. Moreover, the TCR gene expression level of quiescent T cells is low (a few copies per cell), and repertoireanalysis requires high detection sensitivity. IGT's amplification method is one of the most sensitive among existing technologies.

Duplicate clonal analysis of tumor-infiltrating T cells

CD4/CD8 repertoire analysis in cancer tissue:

Fractionation of CD4+ T cells and CD8+ T cells is critical for TCR repertoire analysis. On the other hand, purification of T cell subsets from cancer biopsies is technically and time-consuming. IGT has developed a duplicate clone analysis technology that generates a list of clones belonging to CD4 or CD8 based on the TCR repertoire of CD4+ and CD8+ T cells in the peripheral blood of patients and determines whether the clone present in the TCR repertoire of unfractionated tumor tissue is CD4 or CD8. (patent pending).

This duplicate clone analysis technology allows for easy analysis of changes in tumor-reactive CD4+ and CD8+ T-cell clones before and after treatment or over time.

* Fractionation options for CD4 and CD8 T cells from peripheral blood mononuclear cells are also available.

Peripheral blood TCR analysis by other companies' conventional methods

Tumor-associated T cells are only present in a small portion of the peripheral blood, making difficult to assess.

TCR analysis fpr peripheral blood and tumor duplication by IGT

Any facility can send peripheral blood and tumor biopsies collected at diagnosis to sent to IGT to evaluate specific anti-tumor T-cell responses.

Conventional tumor-infiltrating T-cell leptorenalysis

Simple but not immunologically interpretable.
Time and special techniques are needed to enable immunological interpretation.

Tumor and peripheral blood duplicate clone analysis technology for
versatile tumor-infiltrating CD4/CD8T cells repertoire analysis

Single TCR Repatoir Analysis

By integrating scRNA-seq and TCR repertoire analysis, gene expression information and TCRα/β pair sequences necessary for clone reconstitution can be simultaneously analyzed for individual T cells. Based on the characteristics and frequency of each clone, it is possible to narrow down clones that are promising for TCR gene therapy and other applications.

ImmunoGeneTeqs

Single cell TCR repertoire analysis features

ImmunoGeneTeqs

Single cell TCR repertoire analysis features

・ 

The single-cell RNA-seq performed in this analysis is targeted sequencing using BD's Immune Response Panel, with the option of adding genes related to regulatory T cells, exhausted T cells, etc. Regulatory T cells, exhausted T cells, etc. can be added as an option.

・ 

Up to 20,000-30,000 cells/analysis; pairing efficiency of mouse and human TCRα/β is about 20%-80% (depending on cell activation state)

・ 

Simultaneous analysis with protein using BD's Abseq, BioLegend's TotalSeq, etc. is also available

TAS-Seq2 detects about 3 times more genes than BD's WTA kit

TAS-Seq2 has a higher T-cell receptor pairing rate than BD's WTA kit

sample

sample

TCR alpha total reads

TCR alpha total reads

TCR beta total reads

TCR beta total reads

TCR detected cells

TCR detected cells

TCR paired cell

TCR paired cell

TCR pairing rate

TCR pairing rate

BD WTA

BD WTA

12,955,106

12,955,106

9,457,677

9,457,677

1,076

1,076

613

613

57.0%

57.0%

TAS-Seq2

TAS-Seq2

12,569,275

12,569,275

12,890,758

12,890,758

1,156

1,156

1,005

1,005

86.9%

86.9%

Example of analysis of tumor-infiltrating CD8⁺T cells in a B16F10 subcutaneously implanted tumor mouse model upon anti-PD-L1 treatment (WTA)

Approx. 50,000 reads/cell

EXPRESSION PATTERNS OF REPRESENTATIVE CD8+ T CELL MARKER GENES

BD WTA

TAS-Seq2

TAS-Seq2

Clusters identified by TAS-Seq2

0: terminally exhausted, 1: effector, 2: proliferated, 3: exhausted progenitor-1, 4: exhausted progenitor-2, 5: naïve-like, 6: stem-like, 7: dying cell

・ 

TAS-Seq2 can identify CD8+ T cell subsets that are difficult to identify with BD's WTA kit

・ 

TAS-Seq2 can clearly detect genes involved in the regulation of CD8+ T cell function with a lower drop-out rate